Publications by authors named "Montserrat Torrebadell"

Claim this Profile
P
Pre-TCR-targeted immunotherapy for T cell acute lymphoblastic leukemia.
Patricia Fuentes, Marina García-Peydró, Juan Alcain, Marta Mosquera, Carmela Cela, Montserrat Torrebadell

Nat Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.
Néstor Tirado, Klaudyna Fidyt, María José Mansilla, Alba Garcia-Perez, Alba Martínez-Moreno, Montserrat Torrebadell

J Hematol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet Counts Prior to Lymphodepletion Chemotherapy are Associated with Clinical Outcome in Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia After CAR-T19-Cell Therapy.
Nazaret Sanchez-Sierra, Anna Alonso-Saladrigues, Sara Perez-Jaume, Cristina Rivera-Perez, Anna Faura, Montserrat Torrebadell

Pediatr Blood Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring.
Águeda Molinos-Quintana, Anna Alonso-Saladrigues, Blanca Herrero, Teresa Caballero-Velázquez, Víctor Galán-Gómez, Montserrat Torrebadell

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring.
Águeda Molinos-Quintana, Anna Alonso-Saladrigues, Blanca Herrero, Teresa Caballero-Velázquez, Víctor Galán-Gómez, Montserrat Torrebadell

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells.
Talia Velasco-Hernandez, Juan L Trincado, Meritxell Vinyoles, Adria Closa, Alba Martínez-Moreno, Montserrat Torrebadell

Hemasphere· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A miRNA signature related to stemness identifies high-risk patients in paediatric acute myeloid leukaemia.
Elena Esperanza-Cebollada, Soledad Gómez-González, Sara Perez-Jaume, Nerea Vega-García, Clara Vicente-Garcés, Montserrat Torrebadell

Br J Haematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusion InPipe, an integrative pipeline for gene fusion detection from RNA-seq data in acute pediatric leukemia.
Clara Vicente-Garcés, Joan Maynou, Guerau Fernández, Elena Esperanza-Cebollada, Montserrat Torrebadell

Front Mol Biosci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of ARI-0001 CART19 cell therapy in patients with relapsed/refractory CD19-positive acute lymphoblastic leukemia with isolated extramedullary disease.
Valentín Ortiz-Maldonado, Anna Alonso-Saladrigues, Marta Español-Rego, Nuria Martínez-Cibrián, Anna Faura, Montserrat Torrebadell

Am J Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment.
Laura Garcia-Gerique, Marta García, Alícia Garrido-Garcia, Soledad Gómez-González, Montserrat Torrebadell

BMC Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technical Validation and Clinical Utility of an NGS Targeted Panel to Improve Molecular Characterization of Pediatric Acute Leukemia.
Clara Vicente-Garcés, Elena Esperanza-Cebollada, Sara Montesdeoca, Montserrat Torrebadell, Susana Rives

Front Mol Biosci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report.
Margarita Maurer-Granofszky, Angela Schumich, Barbara Buldini, Giuseppe Gaipa, Janos Kappelmayer, Montserrat Torrebadell

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with the clinical outcome of patients with relapsed/refractory CD19 acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy.
Valentín Ortiz-Maldonado, Susana Rives, Marta Español-Rego, Anna Alonso-Saladrigues, Mercedes Montoro, Montserrat Torrebadell

J Immunother Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19 Relapsed/Refractory Malignancies.
Valentín Ortíz-Maldonado, Susana Rives, Maria Castellà, Anna Alonso-Saladrigues, Daniel Benítez-Ribas, Montserrat Torrebadell

Mol Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.
Nerea Vega-García, Sara Perez-Jaume, Elena Esperanza-Cebollada, Clara Vicente-Garcés, Montserrat Torrebadell

Front Pediatr· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia.
Nerea Vega-Garcia, Rocío Benito, Elena Esperanza-Cebollada, Marta Llop, Cristina Robledo, Montserrat Torrebadell

J Pers Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia.
Diego Sánchez-Martínez, Matteo L Baroni, Francisco Gutierrez-Agüera, Heleia Roca-Ho, Oscar Blanch-Lombarte, Montserrat Torrebadell

Blood· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01.
Guillem Pascual-Pasto, Miriam Bazan-Peregrino, Nagore G Olaciregui, Camilo A Restrepo-Perdomo, Ana Mato-Berciano, Montserrat Torrebadell

Sci Transl Med· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia.
Montserrat Torrebadell, Marina Díaz-Beyá, Susana G Kalko, Marta Pratcorona, Josep Nomdedeu

Leuk Lymphoma· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases.
Nerea Vega-García, Roberta Malatesta, Camino Estella, Sara Pérez-Jaume, Elena Esperanza-Cebollada, Montserrat Torrebadell

Br J Haematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier.
Guillem Pascual-Pasto, Nagore G Olaciregui, Javier A W Opezzo, Helena Castillo-Ecija, Maria Cuadrado-Vilanova, Montserrat Torrebadell

J Control Release· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spuriously low pulse oximetry saturation associated with hemoglobin Sydney in a child and relatives: Identification of this unstable hemoglobin may avoid unnecessary testing and hospital admissions.
Mariona F de Sevilla, Albert Català, Susana Rives, Rubén Berrueco, Nereida Vidiella, Montserrat Torrebadell

Pediatr Blood Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aplastic Crisis Secondary to Parvovirus B19 Infection as the First Manifestation of an Undiagnosed Hereditary Spherocytosis: Report of a Pediatric Series of Spanish Patients.
Anna Alonso-Saladrigues, Albert Català, Rubén Berrueco, Mireia Camós, Montserrat Torrebadell

J Pediatr Hematol Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbial translocation and T cell activation are not associated in chronic HIV-infected children.
Lola Madrid, Antoni Noguera-Julian, Lola Falcon-Neyra, Claudia Fortuny, Beatriz De Felipe, Montserrat Torrebadell

AIDS· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy.
Marta Pratcorona, Salut Brunet, Josep Nomdedéu, Josep Maria Ribera, Mar Tormo, Montserrat Torrebadell

Blood· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis